Supporting information for 'Inkjet printing of a thermolabile model drug onto FDM-printed substrates: formulation and evaluation'.

This copy of the Supplementary Material is subject to the same embargo as the post-print and will be available here from 01/07/21.

If your organisation has a subscription for the journal publisher (sometimes termed ‘authorised user’ or similar), the supplementary files are available online at https://doi.org/10.1080/03639045.2020.1788062